MENU

CTTH Stock CTT Pharmaceutical Holdings (CTTH, $0.03) was a top gainer this month, soaring +10.69%

A.I.dvisor
at Tickeron.com
Loading...
CTTH - CTT Pharmaceutical Holdings, Inc.
Tickeron

Loading...

Price: $0.0321
Daily change: +$0.00083 (+2.65%)
Daily volume: 230K
Monthly price change: +$0.0031 (+10.69%)
Capitalization: $1.8M
Industry: Pharmaceuticals: Other
CTT Pharmaceutical Holdings (CTTH, $0.03) was one of the top gainers for the month, rising +1 to $0.03 per share. A.I.dvisor analyzed 202 stocks in the Pharmaceuticals: Other Industry for the month ending July 18, 2025 and discovered that of them (6) exhibited an Uptrend while of them (3) exhibited a Downtrend.

Aroon Indicator for CTTH shows an upward move is likely

CTTH's Aroon Indicator triggered a bullish signal on July 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 93 similar instances where the Aroon Indicator showed a similar pattern. In of the 93 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 18, 2025. You may want to consider a long position or call options on CTTH as a result. In of 153 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CTTH just turned positive on June 23, 2025. Looking at past instances where CTTH's MACD turned positive, the stock continued to rise in of 77 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CTTH advanced for three days, in of 112 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where CTTH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CTTH broke above its upper Bollinger Band on July 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CTTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (63.056). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). CTTH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (18.472).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CTTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1100 – 1111 Melville Street
Phone
+1 813 606-0060
Employees
3
Web
https://www.cttpharmaceuticals.com